FOXO transcription factors regulate cellular homeostasis, longevity and response to stress. FOXO1 (also known as FKHR) is a key regulator of hepatic glucose production and lipid metabolism, and its specific inhibition may have beneficial effects on diabetic hyperglycemia by reducing hepatic glucose production. Moreover, all FOXO proteins are considered potential drug targets for drug resistance prevention in cancer therapy. However, the development of specific FOXO inhibitors requires a detailed understanding of structural differences between individual FOXO DNA-binding domains. The high-resolution structure of the DNA-binding domain of FOXO1 reported in this study and its comparison with structures of other FOXO proteins revealed differences in both their conformation and flexibility. These differences are encoded by variations in protein sequences and account for the distinct functions of FOXO proteins. In particular, the positions of the helices H1, H2 and H3, whose interface form the hydrophobic core of the Forkhead domain, and the interactions between hydrophobic residues located on the interface between the N-terminal segment, the H2-H3 loop, and the recognition helix H3 differ among apo FOXO1, FOXO3 and FOXO4 proteins. Therefore, the availability of apo structures of DNA-binding domains of all three major FOXO proteins will support the development of FOXO-type-specific inhibitors.

Department of Cell Biology Faculty of Science Charles University 128 43 Prague Czech Republic

Department of Pediatrics 1 Medical University Innsbruck A 6020 Innsbruck Austria

Department of Physical and Macromolecular Chemistry Faculty of Science Charles University 128 43 Prague Czech Republic

Department of Structural Biology of Signaling Proteins Division BIOCEV Institute of Physiology of the Czech Academy of Sciences 252 50 Vestec Czech Republic

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences 166 10 Prague Czech Republic

Zobrazit více v PubMed

Weigel D., Jackle H. The Fork Head Domain—A Novel DNA-Binding Motif of Eukaryotic Transcription Factors. Cell. 1990;63:455–456. doi: 10.1016/0092-8674(90)90439-L. PubMed DOI

Kaestner K.H., Knochel W., Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 2000;14:142–146. PubMed

Clark K.L., Halay E.D., Lai E., Burley S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature. 1993;364:412–420. doi: 10.1038/364412a0. PubMed DOI

Tsai K.L., Huang C.Y., Chang C.H., Sun Y.J., Chuang W.J., Hsiao C.D. Crystal structure of the human FOXK1a-DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins. J. Biol. Chem. 2006;281:17400–17409. doi: 10.1074/jbc.M600478200. PubMed DOI

Stroud J.C., Wu Y., Bates D.L., Han A., Nowick K., Paabo S., Tong H., Chen L. Structure of the forkhead domain of FOXP2 bound to DNA. Structure. 2006;14:159–166. doi: 10.1016/j.str.2005.10.005. PubMed DOI

Tsai K.L., Sun Y.J., Huang C.Y., Yang J.Y., Hung M.C., Hsiao C.D. Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res. 2007;35:6984–6994. doi: 10.1093/nar/gkm703. PubMed DOI PMC

Brent M.M., Anand R., Marmorstein R. Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure. 2008;16:1407–1416. doi: 10.1016/j.str.2008.06.013. PubMed DOI PMC

Boura E., Rezabkova L., Brynda J., Obsilova V., Obsil T. Structure of the human FOXO4-DBD-DNA complex at 1.9 A resolution reveals new details of FOXO binding to the DNA. Acta Crystallogr. D Biol. Crystallogr. 2010;66:1351–1357. doi: 10.1107/S0907444910042228. PubMed DOI

Furuyama T., Nakazawa T., Nakano I., Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 2000;349:629–634. doi: 10.1042/bj3490629. PubMed DOI PMC

Biggs W.H., 3rd, Cavenee W.K., Arden K.C. Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome. 2001;12:416–425. doi: 10.1007/s003350020002. PubMed DOI

O’Brien R.M., Granner D.K. Regulation of gene expression by insulin. Physiol. Rev. 1996;76:1109–1161. doi: 10.1152/physrev.1996.76.4.1109. PubMed DOI

Streeper R.S., Svitek C.A., Chapman S., Greenbaum L.E., Taub R., O’Brien R.M. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J. Biol. Chem. 1997;272:11698–11701. doi: 10.1074/jbc.272.18.11698. PubMed DOI

Overdier D.G., Porcella A., Costa R.H. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol. Cell Biol. 1994;14:2755–2766. doi: 10.1128/MCB.14.4.2755. PubMed DOI PMC

Kaufmann E., Muller D., Knochel W. DNA recognition site analysis of Xenopus winged helix proteins. J. Mol. Biol. 1995;248:239–254. doi: 10.1016/S0022-2836(95)80047-6. PubMed DOI

Hornsveld M., Dansen T.B., Derksen P.W., Burgering B.M.T. Re-evaluating the role of FOXOs in cancer. Semin Cancer Biol. 2018;50:90–100. doi: 10.1016/j.semcancer.2017.11.017. PubMed DOI

Ma J., Matkar S., He X., Hua X. FOXO family in regulating cancer and metabolism. Semin Cancer Biol. 2018;50:32–41. doi: 10.1016/j.semcancer.2018.01.018. PubMed DOI

Tia N., Singh A.K., Pandey P., Azad C.S., Chaudhary P., Gambhir I.S. Role of Forkhead Box O (FOXO) transcription factor in aging and diseases. Gene. 2018;648:97–105. doi: 10.1016/j.gene.2018.01.051. PubMed DOI

Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857–868. doi: 10.1016/S0092-8674(00)80595-4. PubMed DOI

Kops G.J., de Ruiter N.D., De Vries-Smits A.M., Powell D.R., Bos J.L., Burgering B.M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 1999;398:630–634. doi: 10.1038/19328. PubMed DOI

Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., DeCaprio J.A., Greenberg M.E., Yaffe M.B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 2002;156:817–828. doi: 10.1083/jcb.200112059. PubMed DOI PMC

Obsilova V., Vecer J., Herman P., Pabianova A., Sulc M., Teisinger J., Boura E., Obsil T. 14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry. 2005;44:11608–11617. doi: 10.1021/bi050618r. PubMed DOI

Silhan J., Vacha P., Strnadova P., Vecer J., Herman P., Sulc M., Teisinger J., Obsilova V., Obsil T. 14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4. J. Biol. Chem. 2009;284:19349–19360. doi: 10.1074/jbc.M109.002725. PubMed DOI PMC

So C.W., Cleary M.L. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell Biol. 2002;22:6542–6552. doi: 10.1128/MCB.22.18.6542-6552.2002. PubMed DOI PMC

Greer E.L., Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005;24:7410–7425. doi: 10.1038/sj.onc.1209086. PubMed DOI

Vogt P.K., Jiang H., Aoki M. Triple layer control: Phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle. 2005;4:908–913. doi: 10.4161/cc.4.7.1796. PubMed DOI

van der Horst A., Burgering B.M.T. Stressing the role of FoxO proteins in lifespan and disease. Nature Reviews Molecular Cell Biol. 2007;8:440–450. doi: 10.1038/nrm2190. PubMed DOI

Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303:2011–2015. doi: 10.1126/science.1094637. PubMed DOI

van der Horst A., de Vries-Smits A.M., Brenkman A.B., van Triest M.H., van den Broek N., Colland F., Maurice M.M., Burgering B.M. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 2006;8:1064–1073. doi: 10.1038/ncb1469. PubMed DOI

Calnan D.R., Brunet A. The FoxO code. Oncogene. 2008;27:2276–2288. doi: 10.1038/onc.2008.21. PubMed DOI

Webb A.E., Kundaje A., Brunet A. Characterization of the direct targets of FOXO transcription factors throughout evolution. Aging Cell. 2016;15:673–685. doi: 10.1111/acel.12479. PubMed DOI PMC

Hui R.C., Francis R.E., Guest S.K., Costa J.R., Gomes A.R., Myatt S.S., Brosens J.J., Lam E.W. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells. Mol. Cancer Ther. 2008;7:670–678. doi: 10.1158/1535-7163.MCT-07-0397. PubMed DOI

Han C.Y., Cho K.B., Choi H.S., Han H.K., Kang K.W. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis. 2008;29:1837–1844. doi: 10.1093/carcin/bgn092. PubMed DOI

Salcher S., Hagenbuchner J., Geiger K., Seiter M.A., Rainer J., Kofler R., Hermann M., Kiechl-Kohlendorfer U., Ausserlechner M.J., Obexer P. C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma. Mol. Cancer. 2014;13:224. doi: 10.1186/1476-4598-13-224. PubMed DOI PMC

Karadedou C.T., Gomes A.R., Chen J., Petkovic M., Ho K.K., Zwolinska A.K., Feltes A., Wong S.Y., Chan K.Y., Cheung Y.N., et al. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. Oncogene. 2012;31:1845–1858. doi: 10.1038/onc.2011.368. PubMed DOI PMC

Yao S., Fan L.Y., Lam E.W. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance. Semin Cancer Biol. 2018;50:77–89. doi: 10.1016/j.semcancer.2017.11.018. PubMed DOI PMC

Pajvani U.B., Accili D. The new biology of diabetes. Diabetologia. 2015;58:2459–2468. doi: 10.1007/s00125-015-3722-5. PubMed DOI PMC

Langlet F., Haeusler R.A., Linden D., Ericson E., Norris T., Johansson A., Cook J.R., Aizawa K., Wang L., Buettner C., et al. Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling. Cell. 2017;171:824–835 e818. doi: 10.1016/j.cell.2017.09.045. PubMed DOI PMC

Lee W., Tonelli M., Markley J.L. NMRFAM-SPARKY: Enhanced software for biomolecular NMR spectroscopy. Bioinformatics. 2015;31:1325–1327. doi: 10.1093/bioinformatics/btu830. PubMed DOI PMC

Renshaw P.S., Veverka V., Kelly G., Frenkiel T.A., Williamson R.A., Gordon S.V., Hewinson R.G., Carr M.D. Sequence-specific assignment and secondary structure determination of the 195-residue complex formed by the Mycobacterium tuberculosis proteins CFP-10 and ESAT-6. J. Biomol. NMR. 2004;30:225–226. doi: 10.1023/B:JNMR.0000048852.40853.5c. PubMed DOI

Veverka V., Lennie G., Crabbe T., Bird I., Taylor R.J., Carr M.D. NMR assignment of the mTOR domain responsible for rapamycin binding. J. Biomol. NMR. 2006;36(Suppl. 1):3. doi: 10.1007/s10858-005-4324-1. PubMed DOI

Herrmann T., Guntert P., Wuthrich K. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 2002;319:209–227. doi: 10.1016/S0022-2836(02)00241-3. PubMed DOI

Guntert P., Wuthrich K. Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints. J. Biomol. NMR. 1991;1:447–456. doi: 10.1007/BF02192866. PubMed DOI

Shen Y., Delaglio F., Cornilescu G., Bax A. TALOS+: A hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR. 2009;44:213–223. doi: 10.1007/s10858-009-9333-z. PubMed DOI PMC

Harjes E., Harjes S., Wohlgemuth S., Muller K.H., Krieger E., Herrmann C., Bayer P. GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1. Structure. 2006;14:881–888. doi: 10.1016/j.str.2006.03.008. PubMed DOI

Weigelt J., Climent I., Dahlman-Wright K., Wikstrom M. Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4) Biochemistry. 2001;40:5861–5869. doi: 10.1021/bi001663w. PubMed DOI

Wang F., Marshall C.B., Yamamoto K., Li G.Y., Plevin M.J., You H., Mak T.W., Ikura M. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53. J. Mol. Biol. 2008;384:590–603. doi: 10.1016/j.jmb.2008.09.025. PubMed DOI

Kelley L.A., Gardner S.P., Sutcliffe M.J. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. Protein Eng. 1996;9:1063–1065. doi: 10.1093/protein/9.11.1063. PubMed DOI

Lee B., Richards F.M. The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol. 1971;55:379–400. doi: 10.1016/0022-2836(71)90324-X. PubMed DOI

Pierrou S., Hellqvist M., Samuelsson L., Enerback S., Carlsson P. Cloning and characterization of seven human forkhead proteins: Binding site specificity and DNA bending. Embo J. 1994;13:5002–5012. doi: 10.1002/j.1460-2075.1994.tb06827.x. PubMed DOI PMC

Martin A.J., Walsh I., Tosatto S.C. MOBI: A web server to define and visualize structural mobility in NMR protein ensembles. Bioinformatics. 2010;26:2916–2917. doi: 10.1093/bioinformatics/btq537. PubMed DOI

Baar M.P., Brandt R.M.C., Putavet D.A., Klein J.D.D., Derks K.W.J., Bourgeois B.R.M., Stryeck S., Rijksen Y., van Willigenburg H., Feijtel D.A., et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;169:132–147 e116. doi: 10.1016/j.cell.2017.02.031. PubMed DOI PMC

Vacha P., Zuskova I., Bumba L., Herman P., Vecer J., Obsilova V., Obsil T. Detailed kinetic analysis of the interaction between the FOXO4-DNA-binding domain and DNA. Biophys. Chem. 2013;184C:68–78. doi: 10.1016/j.bpc.2013.09.002. PubMed DOI

Golson M.L., Kaestner K.H. Fox transcription factors: From development to disease. Development. 2016;143:4558–4570. doi: 10.1242/dev.112672. PubMed DOI PMC

Benayoun B.A., Caburet S., Veitia R.A. Forkhead transcription factors: Key players in health and disease. Trends Genet. 2011;27:224–232. doi: 10.1016/j.tig.2011.03.003. PubMed DOI

Jacobs F.M., van der Heide L.P., Wijchers P.J., Burbach J.P., Hoekman M.F., Smidt M.P. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 2003;278:35959–35967. doi: 10.1074/jbc.M302804200. PubMed DOI

Xing Y.Q., Li A., Yang Y., Li X.X., Zhang L.N., Guo H.C. The regulation of FOXO1 and its role in disease progression. Life Sci. 2018;193:124–131. doi: 10.1016/j.lfs.2017.11.030. PubMed DOI

Lu H., Huang H. FOXO1: A potential target for human diseases. Current drug targets. 2011;12:1235–1244. doi: 10.2174/138945011796150280. PubMed DOI PMC

Nakae J., Biggs W.H., 3rd, Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 2002;32:245–253. doi: 10.1038/ng890. PubMed DOI

Matsumoto M., Han S., Kitamura T., Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 2006;116:2464–2472. doi: 10.1172/JCI27047. PubMed DOI PMC

Matsumoto M., Pocai A., Rossetti L., Depinho R.A., Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 2007;6:208–216. doi: 10.1016/j.cmet.2007.08.006. PubMed DOI

Cook J.R., Matsumoto M., Banks A.S., Kitamura T., Tsuchiya K., Accili D. A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism. Diabetes. 2015;64:1951–1965. doi: 10.2337/db14-1506. PubMed DOI PMC

Lengthening the Guanidine-Aryl Linker of Phenylpyrimidinylguanidines Increases Their Potency as Inhibitors of FOXO3-Induced Gene Transcription

Modulating FOXO3 transcriptional activity by small, DBD-binding molecules